Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colorectal cancer cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colorectal cancer cells
Authors
Keywords
-
Journal
Oncotarget
Volume 14, Issue 1, Pages 879-889
Publisher
Impact Journals, LLC
Online
2023-10-04
DOI
10.18632/oncotarget.28517
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding Drug Sensitivity and Tackling Resistance in Cancer
- (2022) Jeffrey W. Tyner et al. CANCER RESEARCH
- A phase I clinical trial of trametinib in combination with TAS-102 in patients with chemotherapy-resistant RAS-mutated (PIK3CA/PTEN-wild type) metastatic colorectal cancer
- (2022) Jeremy Chuang et al. Clinical Colorectal Cancer
- Response to BRAF targeted therapy is enhanced by co-targeting VEGFRs or WNT/β-Catenin signaling in BRAF-mutant colorectal cancer models
- (2022) Khanh B. Tran et al. MOLECULAR CANCER THERAPEUTICS
- Drug resistance and Cancer stem cells
- (2021) Yuan Li et al. Cell Communication and Signaling
- Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer
- (2021) Kanan Alshammari et al. Clinical Colorectal Cancer
- Modeling adaptive drug resistance of colorectal cancer and therapeutic interventions with tumor spheroids
- (2021) Astha Lamichhane et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Emerging Role of E2F Family in Cancer Stem Cells
- (2021) Dan Xie et al. Frontiers in Oncology
- Global colorectal cancer burden in 2020 and projections to 2040
- (2021) Yue Xi et al. Translational Oncology
- Colorectal Cancer Stem Cells: An Overview of Evolving Methods and Concepts
- (2021) Maria De Angelis et al. Cancers
- Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors
- (2020) Adewale Oluwaseun Fadaka et al. Cancers
- Quantitative Size-Based Analysis of Tumor Spheroids and Responses to Therapeutics
- (2019) Pradip Shahi Thakuri et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer
- (2019) Mohamed Elbadawy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast
- (2019) Mayuri Prasad et al. MOLECULAR CANCER RESEARCH
- MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer
- (2019) Tianzuo Zhan et al. Nature Communications
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
- (2019) Scott Kopetz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells
- (2019) Waise Quarni et al. Scientific Reports
- Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E -Mutant Colorectal Cancer
- (2018) Ryan B. Corcoran et al. Cancer Discovery
- Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
- (2018) Fang Guo et al. Scientific Reports
- ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells
- (2018) Erika Durinikova et al. BMC CANCER
- Cyclical Treatment of Colorectal Tumor Spheroids Induces Resistance to MEK Inhibitors
- (2018) Pradip Shahi Thakuri et al. Translational Oncology
- Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
- (2017) Xuefeng Liu et al. Nature Protocols
- Three-dimensional tumor model mimics stromal – breast cancer cells signaling
- (2017) Stephanie Lemmo Ham et al. Oncotarget
- Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis
- (2017) Susu Han et al. Oncotarget
- Microprinted Stem Cell Niches Reveal Compounding Effect of Colony Size on Stromal Cells-Mediated Neural Differentiation
- (2017) Ramila Joshi et al. Advanced Healthcare Materials
- Single and Combination Drug Screening with Aqueous Biphasic Tumor Spheroids
- (2017) Pradip Shahi Thakuri et al. SLAS Discovery
- Multiparametric Analysis of Oncology Drug Screening with Aqueous Two-Phase Tumor Spheroids
- (2016) Pradip Shahi Thakuri et al. MOLECULAR PHARMACEUTICS
- Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
- (2016) Wanyin Chen et al. Stem Cells International
- Interfacial Tension Effect on Cell Partition in Aqueous Two-Phase Systems
- (2015) Ehsan Atefi et al. ACS Applied Materials & Interfaces
- Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
- (2015) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer
- (2015) Ryan B. Corcoran et al. JOURNAL OF CLINICAL ONCOLOGY
- Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
- (2015) Stephanie Lemmo Ham et al. Jove-Journal of Visualized Experiments
- High Throughput, Polymeric Aqueous Two-Phase Printing of Tumor Spheroids
- (2014) Ehsan Atefi et al. ADVANCED FUNCTIONAL MATERIALS
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3
- (2014) Chong Sun et al. Cell Reports
- MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors
- (2012) A. B. Turke et al. CANCER RESEARCH
- The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
- (2012) T. Shimizu et al. CLINICAL CANCER RESEARCH
- Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer
- (2011) H. Yang et al. CANCER RESEARCH
- Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition
- (2011) K. P. Hoeflich et al. CANCER RESEARCH
- Characterization of the Intestinal Cancer Stem Cell Marker CD166 in the Human and Mouse Gastrointestinal Tract
- (2010) Trevor G. Levin et al. GASTROENTEROLOGY
- Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer
- (2009) M. L. Sos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started